U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281391) titled 'IOP Reduction in Pigmentary Glaucoma Using DSLT' on Nov. 20.
Brief Summary: This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Study Start Date: Jan. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Pigmentary Dispersion Syndrome
Pigmentary Dispersion Glaucoma
Intervention:
DEVICE: Voyager DSLT
DSLT is an innovative adaptation of traditional SLT. Rather than using a gonioscopic lens, DSLT applies laser energy directly through the limbus to the tr...